Sigma Planning Corp Lantern Pharma Inc. Transaction History
Sigma Planning Corp
- $3.07 Billion
- Q4 2024
A detailed history of Sigma Planning Corp transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 28,450 shares of LTRN stock, worth $139,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,450
Previous 28,650
0.7%
Holding current value
$139,974
Previous $105,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LTRN
# of Institutions
34Shares Held
2.48MCall Options Held
39.8KPut Options Held
6.1K-
Bios Capital Management, LP Fort Worth, TX1.21MShares$5.94 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.79 Million0.0% of portfolio
-
Cm Management, LLC200KShares$984,0000.6% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$675,7020.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$430,1800.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $53.3M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...